← Back to home

FOR CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING (MRI) OF ABNORMAL VASCULAR LESIONS IN BODY REGIONS EXCLUDING THE CENTRAL NERVOUS SYSTEM (CNS)

Clinical trials for FOR CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING (MRI) OF ABNORMAL VASCULAR LESIONS IN BODY REGIONS EXCLUDING THE CENTRAL NERVOUS SYSTEM (CNS) explained in plain language.

Never miss a new study

Get alerted when new FOR CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING (MRI) OF ABNORMAL VASCULAR LESIONS IN BODY REGIONS EXCLUDING THE CENTRAL NERVOUS SYSTEM (CNS) trials appear

Sign up with your email to follow new studies for FOR CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING (MRI) OF ABNORMAL VASCULAR LESIONS IN BODY REGIONS EXCLUDING THE CENTRAL NERVOUS SYSTEM (CNS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New dye aims for sharper MRI pictures of body lesions

Diagnosis Recruiting now

This study is testing a new contrast dye called HRS-9231 for MRI scans of the body (excluding the brain and spine). It aims to see if this new dye works as well as the standard dye, gadobutrol, at making abnormal blood vessel lesions show up clearly on the scan. About 306 adults …

Matched conditions: FOR CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING (MRI) OF ABNORMAL VASCULAR LESIONS IN BODY REGIONS EXCLUDING THE CENTRAL NERVOUS SYSTEM (CNS)

Phase: PHASE3 • Sponsor: Shanghai Shengdi Pharmaceutical Co., Ltd • Aim: Diagnosis

Last updated Mar 23, 2026 15:17 UTC

FOR CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING (MRI) OF ABNORMAL VASCULAR LESIONS IN BODY REGIONS EXCLUDING THE CENTRAL NERVOUS SYSTEM (CNS)

Get alerted when new FOR CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING (MRI) OF ABNORMAL VASCULAR LESIONS IN BODY REGIONS EXCLUDING THE CENTRAL NERVOUS SYSTEM (CNS) trials appear

New dye aims for sharper MRI pictures of body lesions